IDENTIFICATION OF FUNCTIONAL ANTIBODIES THAT CONTROL MYCOBACTERIUM TUBERCULOSIS

Grant number: 1163790 | Funding period: 2019 - 2022

Completed

Abstract

Mycobacterium tuberculosis (MTB) infects one third of the global population, with 10.2 million new cases of TB and 1.1 million million deaths in 2015. This study aims to identify antibodies that target MTB from people that naturally control MTB infection for use as monoclonal antibody therapeutics. We will also identify the immune signals required to induce these protective antibodies. Ultimately, this study will guide the development of future MTB vaccines, therapeutics and diagnostics tools.

Related publications (2)

Serological and cellular inflammatory signatures in end-stage kidney disease and latent tuberculosis

Milla R McLean, Kathleen M Wragg, Ester Lopez, Sandra A Kiazyk, Terry Blake Ball, Joe Bueti, Stephen J Kent, Jennifer A Juno, Amy W Chung

2021-01-01

OBJECTIVES: Tuberculosis comorbidity with chronic diseases including diabetes, HIV and chronic kidney disease is of rising concern..

An Inflammatory Story: Antibodies in Tuberculosis Comorbidities

Mille R McLean, Lenette L Lu, Stephen J Kent, Amy W Chung

2019-12-09

Mycobacterium tuberculosis (Mtb) resides in a quarter of the world's population and is the causative agent for tuberculosis (TB), ..

University of Melbourne Researchers

Amy Chung Microbiology and Immunology

Jennifer Juno Microbiology and Immunology